Lymphoid Neoplasia Resembling Mesothelioma
Case Report
DOI:
https://doi.org/10.55175/cdk.v52i6.1366Keywords:
Lymphoma, mesothelioma, lymphoid neoplasmAbstract
Introduction: Lymphoid neoplasms are abnormalities of the hematopoiesis process of the lymphoid line, which can lead to lymphoma or leukemia. Mesothelioma is an abnormal mesothelial cell growth strongly associated with asbestos exposure. In radiology, mesothelioma is usually described as a tissue-dense lesion with well-defined, spiculated borders attached to the thoracic wall. The picture actually only depicts a tissue attached to the thorax, which can be suspected as mesothelioma, but can also be due to other disease processes, such as leukemia, lymphoma, and tuberculosis. Case: A 58-year-old man presented to the emergency room with complaints of shortness of breath. The patient was initially suspected of mesothelioma with suspicion of blood malignancy, but it turned out that the biopsy results were more likely to lead to infiltration of lymphoid neoplasms. Conclusion: In this patient, a lymphatic neoplasm infiltrated the mesothelial tissue and produced a well-demarcated and spiculated tissue picture resembling mesothelioma. Biopsy examination as the gold standard cannot be replaced by radiologic imaging at this time, as many other disease processes can mimic a malignancy.
Downloads
References
Bispo JAB, Pinheiro PS, Kobetz EK. Epidemiology and etiology of leukemia and lymphoma. Cold Spring Harb Perspect Med. 2020;10(6):a034819. DOI: 10.1101/cshperspect.a034819. PMID: 31727680.
Jain SV, Wallen JM. Malignant mesothelioma [Internet]. 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK519530/.
Li X, Brownlee NA, Sporn TA, Mahar A, Roggli VL. Malignant (diffuse) mesothelioma in patients with hematologic malignancies: Aclinicopathologic study of 45 cases. Arch Pathol Lab Med. 2015;139(9):1129-36. DOI: 10.5858/arpa.2014-0569-OA. PMID: 25844559.
Thouil A, Lakhal M, Bachir H, Bennani A, Kouismi H. Pleurisy as a sign of chronic lymphocytic leukemia. Cureus 2023;15(3):1-5. DOI: 10.7759/cureus.36880.
Brasher W, Faiz S, Patel B, Torres L, Ferrajoli A, Sagar AE, et al. Characteristics ofpleural effusion in chroniclymphocyticleukemia. Chest 2020;158(4):A1188.
Condoluci A, Rossi D. Biology and treatment of Richter transformation. Front Oncol. 2022;12:829983. DOI: 10.3389/fonc.2022.829983. PMID: 35392219.
Nickell Jr LT, Lichtenberger III JP, Khorashadi L, Abbott GF, Carter BW. Multimodality imaging for characterization, classification, and staging of malignant pleural mesothelioma. Radiographics 2014;34(6):1692-706. DOI: 10.1148/rg.346130089.
Carbone M, Adusumilli PS, Alexander HR Jr, Baas P, Bardelli F, Bononi A, et al. Mesothelioma: Scientific clues for prevention, diagnosis, and therapy. CA Cancer J Clin. 2019;69(5):402-29. DOI: 10.3322/caac.21572. Epub 2019 Jul 8. Erratum in: CA Cancer J Clin. 2020 Jul;70(4):313-314. PMID: 31283845.
Nishizawa S, Tobino K. Asymptomatic tuberculous pleurisy mimicking mesothelioma. Am J Respir Crit Care Med. 2020;201(9):1149. DOI: 10.1164/rccm.201906-1223IM. PMID: 31765596.
Nakayama S, Matsuda M, Adachi T, Sueda S, Ueda K, Kawahara K, et al. Tumor necrosis factor- and interleukin-6-producing high-grade B-cell lymphoma, not otherwise specified in the pleura. Leuk Res Rep. 2018;10:1-3. DOI: 10.1016/j.lrr.2018.06.001. PMID: 9998057.
Ito T, Fujita K, Okamura M, Okuno Y, Saito Z, Kanai O, et al. Pleural involvement of diffuse large B-cell lymphoma mimicking malignant pleural mesothelioma. Respir Med Case Rep. 2020;31:101206. DOI: 10.1016/j.rmcr.2020.101206. PMID: 32944500.
Senthil R, Visakh RA, Pratap T, Mahadevan P, Gangadharan VP. Atypical presentation of T-cell large granular lymphocytic leukemia mimicking pleural malignancy on 18F-FDG PET/CT. Clin Nucl Med. 2019;44(4):e296-7. DOI: 10.1097/RLU.0000000000002425. PMID: 30624264.
Shen Y, Coyle L, Kerridge I, Stevenson W, Arthur C, McKinlay N, et al. Second primary malignancies in chronic lymphocytic leukaemia: skin, solid organ, haematological and Richter's syndrome. Ejhaem. 2022;3(1):129-38. DOI: 10.1002/jha2.366.
Manusow D, Weinerman BH. Subsequent neoplasia in chronic lymphocytic leukemia. JAMA. 1975;232(3):267-9.PMID: 47401.
Benjamini O, Jain P, Trinh L, Qiao W, Strom SS, Lerner S, et al. Second cancers in patients with chronic lymphocytic leukemia who received frontline FCR therapy–distribution and clinical outcomes. Leukemia Lymphoma. 2015;56(6):1643. DOI: 10.3109/10428194.2014.957203.
Bond DA, Huang Y, Fisher JL, Ruppert AS, Owen DH, Bertino EM, et al. Second cancer incidence in CLL patients receiving BTK inhibitors. Leukemia 2020;34(12):3197-205.DOI: 10.1038/s41375-020-0987-6.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Irianto, Made Widya Wirayanti Puteri, I Wayan Sunaka, Novitasari

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.